Aller au contenu principal
CAS 1 fiche

CAS 100-97-0

Le CAS 100-97-0 correspond à 1 fiche d’annexe de l’UE dans les annexes II à VI du règlement (CE) n° 1223/2009.

Fiches pour le CAS 100-97-0

1 au total

Identité et propriétés chimiques

Structure chimique 2D PubChem pour le CAS 100-97-0
CAS 100-97-0PubChem CID 4101

Hexamethylenetetramine

Hexamethylenetetramine is a polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms. It has a role as an antibacterial drug. It is a polycyclic cage, a tetramine and a polyazaalkane. — ChEBI

Nom IUPAC
1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane
Formule moléculaire
C6H12N4
Masse moléculaire
140.19 g/mol
Masse exacte
140.106196400 Da
XLogP3
0,3
Surface polaire topologique
13,0 Ų
Donneurs de liaisons hydrogène
0
Accepteurs de liaisons hydrogène
4
Unités covalentes
1
Stéréocentres définis
0

Également connu sous le nom de

methenamineHexamineUrotropineUrotropin1,3,5,7-TetraazaadamantaneUritoneHMTAHexamethylenamine
16 autres noms signalés
FormamineHexamethylene tetramineMethenaminAmmoformCystaminCystogenAmmonioformaldehydeForminAceto HMTHexamethylenetetraamineAminoformaldehydePreparation AFAntihydralDuirexolHexaformMetenamina
Identifiants de bases de données externes

Preuves issues de bases de données scientifiques complémentaires

EMBL-EBI ChEBI
Correspondance exacte d’identifiantCHEBI:6824

hexamethylenetetramine

A polycyclic cage that is adamantane in which the carbon atoms at positions 1, 3, 5 and 7 are replaced by nitrogen atoms.

Formule
C6H12N4
Masse moyenne
140.190 g/mol
Masse monoisotopique
140.10620 Da
Charge formelle
0
  • polycyclic cage — is a (CHEBI:33640)
  • polyazaalkane — is a (CHEBI:39474)
  • tetramine — is a (CHEBI:39166)
  • antibacterial drug — has role (CHEBI:36047)
  • antibacterial agent — has role (CHEBI:33282)
  • antibacterial drug — has role (CHEBI:36047)
  • antibacterial agent — has role (CHEBI:33282)
  • polycyclic cage — is a (CHEBI:33640)
  • polyazaalkane — is a (CHEBI:39474)
  • tetramine — is a (CHEBI:39166)
Noms supplémentaires validés
1,3,5,7-tetraazaadamantane1,3,5,7-tetraazatricyclo[3.3.1.1(3,7)]decaneAminoformE-239E239hexamethylenaminehexamethylene tetraminehexamethylenetetramineHexamethylentetraminhexamethylentetraminumhexaminehexaminumHMTHMTAINS-239INS NO.239methenamineNSC-26346NSC-403347
Références croisées de cette source
  • CAS: 100-97-0 — ChemIDplus
  • CAS: 100-97-0 — NIST Chemistry WebBook
  • REGISTRY_NUMBER: 2018 — Reaxys
  • REGISTRY_NUMBER: 26964 — Gmelin
  • MANUAL_X_REF: 3344 — DrugCentral
  • MANUAL_X_REF: D00393 — KEGG DRUG
  • MANUAL_X_REF: HMDB0029598 — HMDB
  • MANUAL_X_REF: LSM-5440 — LINCS
  • MANUAL_X_REF: Methenamine — Wikipedia
  • MANUAL_X_REF: US2762799 — Patent
  • MANUAL_X_REF: US2762800 — Patent

Mis en correspondance par: Exact CAS cross-reference in the ChEBI compound record. Source mise à jour le: 2017-02-22. Récupéré le: 2026-08-31. Ouvrir la fiche source

NIH PubChem PUG-View
Correspondance exacte d’identifiant4101

Attributed physical-property, hazard, environmental and use annotations.

  • First Aid: EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.; SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.; INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) shou Source: CAMEO Chemicals
  • ERG2024, Guide 133 (Hexamethylenetetramine): General First Aid:; · Call 911 or emergency medical service.; · Ensure that medical personnel are aware of the material(s) involved, take precautions to protect themselves and avoid contamination.; · Move victim to fresh air if it can be done safely.; · Administer oxygen if breathing is difficult.; · If victim is not breathing:; -- DO NOT perform mouth-to-mouth resuscitation; the victim may have ingested or inhaled the substance.; -- If equipped and pulse detected, wash face and mouth, then give artificial respiration using a proper respiratory medical device (bag-valve mask, pocket mask equipped with a one-way valve or other device).; -- If no pulse detected or no respiratory medical device available, provide continuous compressions. Conduct a pulse check every two minutes or monitor for any signs of spontaneous respirations.; · Remove and isolate contaminated clothing and shoes.; · For minor skin contact, avoid spreading material on unaffected skin.; · In case of contact with substance, remove immediately by flushing skin or eyes with running water for at least 20 minutes.; · For severe burns, immediate medical attention is required.; · Effects of exposure (inhalation, ingestion, Source: Emergency Response Guidebook (ERG)
  • Signal: Warning Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • GHS Hazard Statements: H228: Flammable solid [Danger Flammable solids]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin] Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Precautionary Statement Codes: P210, P240, P241, P261, P272, P280, P302+P352, P321, P333+P317, P362+P364, P370+P378, and P501 (click each P-code to see the statement) Source: Regulation (EC) No 1272/2008 of the European Parliament and of the Council
  • Signal: Danger Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H228 (100%): Flammable solid [Danger Flammable solids]; H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P210, P240, P241, P261, P272, P280, P302+P352, P321, P333+P317, P362+P364, P370+P378, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 1051 reports by companies from 19 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • GHS Hazard Statements: H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]; H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]; H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H334 (100%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]; H351 (100%): Suspected of causing cancer [Warning Carcinogenicity] Source: European Chemicals Agency (ECHA)
  • Precautionary Statement Codes: P203, P233, P260, P261, P264, P270, P271, P272, P280, P284, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P318, P321, P330, P333+P317, P342+P316, P362+P364, P363, P403, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
  • ECHA C&L Notifications Summary: Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
  • Signal: Danger Source: NITE-CMC
  • GHS Hazard Statements: H228: Flammable solid [Danger Flammable solids]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H361: Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]; H372: Causes damage to organs through prolonged or repeated exposure [Danger Specific target organ toxicity, repeated exposure] Source: NITE-CMC
  • Cosmetic Ingredient Review Conclusion: On the basis of the animal and clinical data presented in this report, the CIR Expert Panel concludes that Methenamine is safe for cosmetic use at concentrations not to exceed 0.16% in formulation. It cannot be concluded that Methenamine is safe for use in cosmetic products intended to be aerosolized. Source: Cosmetic Ingredient Review (CIR)
  • Cosmetic Ingredient Review Finding(s): Safe for use in cosmetics, with qualifications Source: Cosmetic Ingredient Review (CIR)
  • Toxicity Summary: IDENTIFICATION AND USE: Methenamine is a white or colorless crystalline solid. It is an anti-infective agent. Methenamine hippurate tablets, USP are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. Non-medical uses include the following: in adhesives, coatings, and sealing compounds; as cross-linking agent for hardening phenol-formaldehyde resin and vulcanizing rubber; as corrosion inhibitor for steel; as fuel tablets for camping stoves; as stabilizer for lubricating and insulating oils; in the chemical detection of metals; in the preservation of hides; as dye fixative; for the manufacture of explosive compounds; antimicrobial food additive. HUMAN EXPOSURE AND TOXICITY: GI distress frequently is caused by doses >500 mg four times a day, even with enteric coated tablets. Painful and frequent micturition, albuminuria, hematuria, and rashes may result from doses of 4 to 8 g/day given for longer than 3-4 weeks. Inhalation may cause asthma-like reactions in previously sensitized individuals. Vapors or solutions have produced skin irritation. Methenamine does not appear to be linked to con Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Bioconcentration: An estimated BCF of 3 was calculated in fish for methenamine(SRC), using a log Kow of -2.18(1) and a regression-derived equation(2). According to a classification scheme(2), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 10(SRC), determined from a structure estimation method(2), indicates that methenamine is expected to have very high mobility in soil(SRC). The pKa of methenamine is 4.89(3), indicating that this compound will exist partially in cation form in the environment and cations generally adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(4). Volatilization of methenamine from moist soil surfaces is not expected to be an important fate process(SRC) given an estimated Henry's Law constant of 3.7X10-10 atm-cu m/mole(SRC), derived from its vapor pressure, 6.1X10-4 mm Hg(5), and water solubility, 3.02X10+5 mg/L(6). Methenamine is not expected to volatilize from dry soil surfaces based on its vapor pressure(SRC). Various biolodegradation screening studies have observed between 28-100% degradation of methenamine(7) suggesting that biodegradation is an important environmental fate process in soil(SRC). However, part (or most) of the degradation may be explained by hydrolysis to form formaldehyde and ammonia followed by biodegradation with the degradation rate increasing wi Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 10(SRC), determined from a structure estimation method(2), indicates that methenamine is not expected to adsorb to suspended solids and sediment(SRC). Volatilization from water surfaces is not expected(3) based upon an estimated Henry's Law constant of 3.7X10-10 atm-cu m/mole(SRC), derived from its vapor pressure, 6.1X10-4 mm Hg(4), and water solubility, 3.02X10+5 mg/L(5). According to a classification scheme(6), an estimated BCF of 3(SRC), from its log Kow of -2.18(7) and a regression-derived equation(2), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Various biolodegradation screening studies have observed between 28-100% degradation of methenamine(8) suggesting that biodegradation is an important environmental fate process in soil(SRC). However, part (or most) of the degradation may be explained by hydrolysis to form formaldehyde and ammonia followed by biodegradation with the degradation rate increasing with acidity(8). Aqueous hydrolysis half-lives of 13.8 hours and 1.6 hours have been measured at 37.5 °C and pH 5.8 and pH 2 respectively(9). Source: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), methenamine, which has a vapor pressure of 6.1X10-4 mm Hg at 25 °C(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase methenamine is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 45 minutes(SRC), calculated from its rate constant of 5.1X10-10 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Particulate-phase methenamine may be removed from the air by wet and dry deposition(SRC). Source: Hazardous Substances Data Bank (HSDB)
  • Industry Uses: Chemical reaction regulator; Monomers; Processing aids not otherwise specified; Binder; Other; Energy Releasers (explosives, motive propellant); Polymerization promoter; Terminator/Blocker; Processing aids, specific to petroleum production; Intermediate; Hardener; Adhesion/cohesion promoter; Not Known or Reasonably Ascertainable; Catalyst Source: EPA Chemical Data Reporting (CDR)
  • Cosmetic Ingredient Review Link: CIR ingredient: Methenamine Source: Cosmetic Ingredient Review (CIR)
  • Sources/Uses: Used in adhesives, coatings, sealants, and leather preservatives; also used as an anticorrosion agent, antibiotic, dye fixative, chemical stabilizer, and curing agent for formaldehyde resins and rubber; [HSDB] Used as a drug (methenamine) taken by mouth to prevent recurrent urinary tract infections; [Medscape DrugInfo] Used as a hardener for epoxy resins of the bisphenol A type; Used in the tire, rubber, foundry, and phenol-formaldehyde resin industries; Sometimes used in topical drugs and cosmetics; [Kanerva, p. 1811] Used as a formaldehyde releaser for photographic film development. [Kanerva, p. 1054-5] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Industrial Processes with risk of exposure: Molding and Core Making [Category: Foundry]; Painting (Pigments, Binders, and Biocides) [Category: Paint]; Working with Glues and Adhesives [Category: Other]; Plastic Composites Manufacturing [Category: Industry]; Leather Tanning and Processing [Category: Industry]; Photographic Processing [Category: Other] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
  • Uses: Anti-Infective Agents, Urinary Source: Hazardous Substances Data Bank (HSDB)
  • Uses: For methenamine (USEPA/OPP Pesticide Code: 045501) there are 0 labels match. /SRP: Not registered for current use in the U.S., but approved pesticide uses may change periodically and so federal, state and local authorities must be consulted for currently approved uses./ Source: Hazardous Substances Data Bank (HSDB)
  • Uses: HMTA is used in the rubber industry to prevent vulcanized rubber from blocking and as a accelerator, as a curing agent for thermosetting resins (particularly phenyl-formaldehyde and urea-formaldehyde resins; in foundry mold castings as part of binder resins, in the production of nitrilotriacetic acid; in the manufacture of adhesives and coatings; in firelogs and briquettes for camping; and in flame-retardent materials. Because of its unique ability to hydrolyze to formaldehyde and ammonia under acidic conditions, it is also used in pharmaceuticals, for intestinal infection, and as a preservative in the food industry. Source: Hazardous Substances Data Bank (HSDB)
  • Uses: In adhesives, coatings, and sealing compounds; as cross-linking agent for hardening phenol-formaldehyde resin and vulcanizing rubber; as corrosion inhibitor for steel; as fuel tablets for camping stoves; as stabilizer for lubricating and insulating oils; in the chemical detection of metals; in the preservation of hides; as dye fixative; for the manufacture of explosive compounds; antimicrobial food additive; detection of metals. Source: Hazardous Substances Data Bank (HSDB)
  • Uses: For more Uses (Complete) data for METHENAMINE (9 total), please visit the HSDB record page. Source: Hazardous Substances Data Bank (HSDB)
  • Uses: Use (kg; approx.) in Germany (2009): >500; Use (kg; exact) in Germany (2009): 670; Consumption (g per capita; approx.) in Germany (2009): 0.00611; Consumption (g per capita; exact) in Germany (2009): 0.00818; Calculated removal (%): 8.8 Source: NORMAN Suspect List Exchange

Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source

Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.

Couverture des sources complémentaires et état des correspondances
SourceRésultatVérifié
EMBL-EBI ChEBICorrespondance exacte2026-08-31
NIH PubChem PUG-ViewCorrespondance exacte2026-08-31

Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.

Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Comment le CAS 100-97-0 est utilisé sur ce site

Le CAS 100-97-0 est l’identifiant du Chemical Abstracts Service utilisé pour rattacher cette page à une substance précise. Dans le jeu de données actuel, 1 fiche d’annexe de l’UE partage cet identifiant, ce qui vous aide à vérifier si la même substance apparaît dans un seul contexte réglementaire ou dans plusieurs.

Utilisez cette page lorsqu’une spécification fournisseur, une FDS ou un dossier de matière première vous donne le CAS 100-97-0 et que vous devez voir au même endroit toutes les fiches liées des annexes II à VI. Les cartes d’entrées ci-dessus sont le moyen le plus rapide d’accéder aux limites de concentration, aux avertissements, à l’annexe concernée et aux conditions par type de produit.

Questions fréquentes

Une substance identifiée par le CAS 100-97-0 peut figurer dans plusieurs annexes du règlement de l’UE sur les cosmétiques lorsqu’elle est soumise à des conditions différentes selon les contextes. Par exemple, une substance peut être soumise à restrictions à l’annexe III avec des conditions précises, et le même CAS peut aussi figurer à l’annexe IV comme colorant autorisé, dans une entrée distincte avec ses propres conditions. Chaque entrée doit être examinée individuellement.

Recoupez le numéro CAS avec les fiches de spécification de vos matières premières et vos certificats d’analyse. Lorsqu’un CAS figure à l’annexe II, vérifiez son absence. Lorsqu’il figure à l’annexe III, vérifiez que les limites de concentration et les conditions de type de produit sont respectées dans votre formulation. Toutes les entrées d’annexe partageant ce numéro CAS sont énumérées ci-dessus.

Un numéro CAS est attribué par le Chemical Abstracts Service (États-Unis) et reconnu dans le monde entier. Un numéro CE est un identifiant de la Commission européenne issu d’inventaires tels que l’EINECS, l’ELINCS ou la liste NLP. Les deux identifiants peuvent figurer dans les entrées des annexes cosmétiques de l’UE. Certaines substances ont les deux, d’autres un seul, et certaines entrées plus anciennes peuvent n’en avoir aucun.

Le vérificateur INCI accepte les noms d’ingrédients, les numéros CAS et les numéros CE. Vérifiez directement ce numéro CAS, puis contrôlez le résultat auprès des fiches de spécification des fournisseurs et de toutes les conditions d’annexe associées.

Outils et étapes suivantes

Vérifiez votre formule

Analysez une liste INCI complète, puis utilisez le CAS 100-97-0 pour recouper les documents fournisseurs relatifs aux substances identifiées.

Vérificateur INCI

Parcourir les annexes

Parcourez toutes les annexes du règlement de l’UE sur les cosmétiques par catégorie.

Toutes les annexes

Rechercher par nom

Recherchez les noms INCI, alias ou identifiants associés qui figurent à côté du CAS 100-97-0 dans votre documentation.

Rechercher